羊膜干细胞治疗犬慢性脊髓损伤的初步结果。

IF 1.7 Q4 CELL BIOLOGY Stem Cells and Cloning-Advances and Applications Pub Date : 2021-10-18 eCollection Date: 2021-01-01 DOI:10.2147/SCCAA.S324184
Jéssica Rodrigues Orlandin, Ingrid da Silva Gomes, Shamira de Fátima Sallum Leandro, Artur Fuertes Cagnim, Juliana Barbosa Casals, Adriano Bonfim Carregaro, Silvio Henrique Freitas, Luciana Cristina Machado, Maria Cristina Reis Castiglioni, Ana Liz Garcia Alves, Vânia Maria de Vasconcelos Machado, Carlos Eduardo Ambrósio
{"title":"羊膜干细胞治疗犬慢性脊髓损伤的初步结果。","authors":"Jéssica Rodrigues Orlandin,&nbsp;Ingrid da Silva Gomes,&nbsp;Shamira de Fátima Sallum Leandro,&nbsp;Artur Fuertes Cagnim,&nbsp;Juliana Barbosa Casals,&nbsp;Adriano Bonfim Carregaro,&nbsp;Silvio Henrique Freitas,&nbsp;Luciana Cristina Machado,&nbsp;Maria Cristina Reis Castiglioni,&nbsp;Ana Liz Garcia Alves,&nbsp;Vânia Maria de Vasconcelos Machado,&nbsp;Carlos Eduardo Ambrósio","doi":"10.2147/SCCAA.S324184","DOIUrl":null,"url":null,"abstract":"<p><strong>Introduction: </strong>Intervertebral disc diseases (IVDD) represent the majority of neurological attendance and responsible for the most cases of paralysis in dogs. Treatments currently used do not show satisfactory results in patients with more severe and chronic neurological manifestations.</p><p><strong>Methods: </strong>To promote nerve and muscular recovery, as well as improve quality of life, we aimed to create a double-blind test method, associating spinal decompression surgery and allogeneic transplantation of amniotic membrane-derived stem cells (AMSCs) in dogs with chronic IVDD. Cells were characterized as fetal mesenchymal cells and safe for application. Eight animals completed the experiment: stem cell applications were made in four animals that had previously undergone an unsuccessful surgical procedure (\"SC group\", n = 4); two animals were submitted to surgery, followed by applications of stem cells (\"Surgery + SC\", n = 2); two other animals were submitted to surgery, followed by the application of saline solution (\"Surgery + placebo\", n = 2). During the surgical procedure, a topical application was performed on the lesion and after fifteen and forty-five days another two applications were made via epidural. Animals were monitored biweekly and reassessed three months after surgery, by functional tests and magnetic resonance exams.</p><p><strong>Results: </strong>Some animals presented significant neurological improvement, such as the recovery of nociception and ability to remain on station. Despite the need further studies, until the present moment, cell therapy has been feasible and has no harmful effects on animals.</p><p><strong>Conclusion: </strong>The protocol of preclinical trial showed the association with decompressive surgery and cell transplantation in dogs with thoracolumbar IVDD proved feasible, and it was possible to observe neurological improvement after treatment. No tissue improvement through MRI was found. The double-blind test guaranteed reliability of the evaluations and results obtained that, even with a small sample size, generated satisfactory results for the animals and owners.</p>","PeriodicalId":44934,"journal":{"name":"Stem Cells and Cloning-Advances and Applications","volume":"14 ","pages":"39-49"},"PeriodicalIF":1.7000,"publicationDate":"2021-10-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/90/41/sccaa-14-39.PMC8536879.pdf","citationCount":"2","resultStr":"{\"title\":\"Treatment of Chronic Spinal Cord Injury in Dogs Using Amniotic Membrane-Derived Stem Cells: Preliminary Results.\",\"authors\":\"Jéssica Rodrigues Orlandin,&nbsp;Ingrid da Silva Gomes,&nbsp;Shamira de Fátima Sallum Leandro,&nbsp;Artur Fuertes Cagnim,&nbsp;Juliana Barbosa Casals,&nbsp;Adriano Bonfim Carregaro,&nbsp;Silvio Henrique Freitas,&nbsp;Luciana Cristina Machado,&nbsp;Maria Cristina Reis Castiglioni,&nbsp;Ana Liz Garcia Alves,&nbsp;Vânia Maria de Vasconcelos Machado,&nbsp;Carlos Eduardo Ambrósio\",\"doi\":\"10.2147/SCCAA.S324184\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Introduction: </strong>Intervertebral disc diseases (IVDD) represent the majority of neurological attendance and responsible for the most cases of paralysis in dogs. Treatments currently used do not show satisfactory results in patients with more severe and chronic neurological manifestations.</p><p><strong>Methods: </strong>To promote nerve and muscular recovery, as well as improve quality of life, we aimed to create a double-blind test method, associating spinal decompression surgery and allogeneic transplantation of amniotic membrane-derived stem cells (AMSCs) in dogs with chronic IVDD. Cells were characterized as fetal mesenchymal cells and safe for application. Eight animals completed the experiment: stem cell applications were made in four animals that had previously undergone an unsuccessful surgical procedure (\\\"SC group\\\", n = 4); two animals were submitted to surgery, followed by applications of stem cells (\\\"Surgery + SC\\\", n = 2); two other animals were submitted to surgery, followed by the application of saline solution (\\\"Surgery + placebo\\\", n = 2). During the surgical procedure, a topical application was performed on the lesion and after fifteen and forty-five days another two applications were made via epidural. Animals were monitored biweekly and reassessed three months after surgery, by functional tests and magnetic resonance exams.</p><p><strong>Results: </strong>Some animals presented significant neurological improvement, such as the recovery of nociception and ability to remain on station. Despite the need further studies, until the present moment, cell therapy has been feasible and has no harmful effects on animals.</p><p><strong>Conclusion: </strong>The protocol of preclinical trial showed the association with decompressive surgery and cell transplantation in dogs with thoracolumbar IVDD proved feasible, and it was possible to observe neurological improvement after treatment. No tissue improvement through MRI was found. The double-blind test guaranteed reliability of the evaluations and results obtained that, even with a small sample size, generated satisfactory results for the animals and owners.</p>\",\"PeriodicalId\":44934,\"journal\":{\"name\":\"Stem Cells and Cloning-Advances and Applications\",\"volume\":\"14 \",\"pages\":\"39-49\"},\"PeriodicalIF\":1.7000,\"publicationDate\":\"2021-10-18\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/90/41/sccaa-14-39.PMC8536879.pdf\",\"citationCount\":\"2\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Stem Cells and Cloning-Advances and Applications\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.2147/SCCAA.S324184\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2021/1/1 0:00:00\",\"PubModel\":\"eCollection\",\"JCR\":\"Q4\",\"JCRName\":\"CELL BIOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Stem Cells and Cloning-Advances and Applications","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.2147/SCCAA.S324184","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2021/1/1 0:00:00","PubModel":"eCollection","JCR":"Q4","JCRName":"CELL BIOLOGY","Score":null,"Total":0}
引用次数: 2

摘要

简介:椎间盘疾病(IVDD)代表了大多数神经系统疾病,并负责大多数犬瘫痪病例。目前使用的治疗方法在更严重和慢性神经症状的患者中没有显示出令人满意的结果。方法:为了促进神经和肌肉的恢复,提高生活质量,我们旨在建立一种双盲试验方法,将脊髓减压手术与羊膜来源干细胞(AMSCs)移植在慢性IVDD犬中进行关联。细胞为胎儿间充质细胞,可安全应用。8只动物完成了实验:干细胞应用于4只先前经历过不成功手术的动物(“SC组”,n = 4);2只动物接受手术,随后应用干细胞(“手术+ SC”,n = 2);另外两只动物接受手术,随后应用生理盐水溶液(“手术+安慰剂”,n = 2)。在手术过程中,病灶局部应用,15天和45天后,另外两次通过硬膜外应用。每两周对动物进行监测,并在手术后三个月通过功能测试和磁共振检查重新评估。结果:部分动物神经系统有明显改善,如痛觉恢复、站立能力恢复等。尽管还需要进一步的研究,但到目前为止,细胞疗法是可行的,而且对动物没有有害影响。结论:临床前试验方案表明,胸腰椎IVDD与减压手术和细胞移植的关联是可行的,治疗后可以观察到神经系统的改善。MRI未见组织改善。双盲测试保证了评估和结果的可靠性,即使样本量很小,也为动物和主人产生了满意的结果。
本文章由计算机程序翻译,如有差异,请以英文原文为准。

摘要图片

摘要图片

摘要图片

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
Treatment of Chronic Spinal Cord Injury in Dogs Using Amniotic Membrane-Derived Stem Cells: Preliminary Results.

Introduction: Intervertebral disc diseases (IVDD) represent the majority of neurological attendance and responsible for the most cases of paralysis in dogs. Treatments currently used do not show satisfactory results in patients with more severe and chronic neurological manifestations.

Methods: To promote nerve and muscular recovery, as well as improve quality of life, we aimed to create a double-blind test method, associating spinal decompression surgery and allogeneic transplantation of amniotic membrane-derived stem cells (AMSCs) in dogs with chronic IVDD. Cells were characterized as fetal mesenchymal cells and safe for application. Eight animals completed the experiment: stem cell applications were made in four animals that had previously undergone an unsuccessful surgical procedure ("SC group", n = 4); two animals were submitted to surgery, followed by applications of stem cells ("Surgery + SC", n = 2); two other animals were submitted to surgery, followed by the application of saline solution ("Surgery + placebo", n = 2). During the surgical procedure, a topical application was performed on the lesion and after fifteen and forty-five days another two applications were made via epidural. Animals were monitored biweekly and reassessed three months after surgery, by functional tests and magnetic resonance exams.

Results: Some animals presented significant neurological improvement, such as the recovery of nociception and ability to remain on station. Despite the need further studies, until the present moment, cell therapy has been feasible and has no harmful effects on animals.

Conclusion: The protocol of preclinical trial showed the association with decompressive surgery and cell transplantation in dogs with thoracolumbar IVDD proved feasible, and it was possible to observe neurological improvement after treatment. No tissue improvement through MRI was found. The double-blind test guaranteed reliability of the evaluations and results obtained that, even with a small sample size, generated satisfactory results for the animals and owners.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
CiteScore
6.50
自引率
0.00%
发文量
10
审稿时长
16 weeks
期刊最新文献
Autologous Bone Marrow-Derived Mesenchymal Stem Cells in the Reversal of Unobstructed Azoospermia in Rats. Assessment of the Dose-Dependent Effect of Human Platelet Lysate on Wharton's Jelly-Derived Mesenchymal Stem/Stromal Cells Culture for Manufacturing Protocols. A Comprehensive Review of Stem Cell Conditioned Media Role for Anti-Aging on Skin. Intraperitoneal Injection of Graphene Oxide Nanoparticle Accelerates Stem Cell Therapy Effects on Acute Kidney Injury [Retraction]. A Thinkful of "Alginate Beads as a Promising Tool for Successful Production of Viable and Pluripotent Human-Induced Pluripotent Stem Cells in a 3D Culture System" [Letter].
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1